CSL, 일리노이 혈장 치료제 생산 시설 확장 발표
Thursday, March 12, 2026
2 min read
정규 소스Australia
Standard Coverage40%
변경 사항
CSL은 일리노이주 캔카키에 있는 혈장 치료제 생산 시설 확장을 위해 15억 달러를 투자한다고 발표했으며, 이를 통해 최소 300개의 신규 일자리가 창출될 예정입니다.
Key Figures
$1.5 billion investmentCSL's investment to expand its Illinois plasma therapy manufacturing facility.
at least 300 new jobsNumber of new jobs expected from the facility expansion.
Source Report
CSL announced a $1.5 billion investment to expand its plasma therapy manufacturing facility in Kankakee, Illinois, which is expected to create at least 300 new jobs.
Sigvera Intelligence
Industry Context
Healthtech & Biotech
Where this signal fits in the broader landscape.
110 산업 시그널Expansion
Company Activity전체 보기
Source Verification
Verified from official source
Publisher—
게시일Mar 12, 2026
소스 분류Verified Canonical
시그널 타임라인
최초 보도Mar 12, 2026
인덱싱Mar 12, 2026
게시Mar 12, 2026
https://newsroom.csl.com/2026-03-09-CSL-announces-expansion-of-Illinois-plasma-therapy-manufacturing-facility
Read Full Source신뢰도:88%
Get cross-language signal intelligence
Get curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
My Notes
Sign in to save notes on signals.
로그인